Clinical Trials
34
Active:1
Completed:14
Trial Phases
5 Phases
Phase 1:1
Phase 2:2
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (26 trials with phase data)• Click on a phase to view related trials
Not Applicable
17 (65.4%)Phase 4
5 (19.2%)Phase 2
2 (7.7%)Phase 1
1 (3.8%)Phase 3
1 (3.8%)Remiazolam vs Propofol Total Intravenous Anesthesia on Postoperative Neurodevelopment After General Anesthesia in Children
Not Applicable
Not yet recruiting
- Conditions
- Adenotonsillar Hypertrophy
- Interventions
- First Posted Date
- 2025-09-26
- Last Posted Date
- 2025-09-26
- Target Recruit Count
- 558
- Registration Number
- NCT07194109
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
Not Applicable
Active, not recruiting
- Conditions
- Objective Response Rate for Neoadjuvant Chemotherapy, ORR
- Interventions
- Biological: Sintilimab combined with XELOX
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-17
- Target Recruit Count
- 50
- Registration Number
- NCT07127497
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, An Hui, China
Study on the Recovery of Visual Perceptual Function Dysfunction in Patients With Diabetes
Not Applicable
Completed
- Conditions
- Diabetic Retinopathy (DR)Visual Perception
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Target Recruit Count
- 36
- Registration Number
- NCT07095777
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery
Not Applicable
Not yet recruiting
- Conditions
- After Cardiac SurgeryDiuretic Resistance
- Interventions
- Drug: rhBNP and standard basic treatment
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Target Recruit Count
- 120
- Registration Number
- NCT07086287
- Locations
- 🇨🇳
the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
Recruiting
- Conditions
- ESCCRadiomicsLymph Node Metastasis
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 500
- Registration Number
- NCT07050576
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found